Medical Cannabis for Glaucoma: Dosage Research at a Glance
There is no established medical cannabis dosage for glaucoma. Research shows that THC can lower intraocular pressure (IOP) by about 20 to 30 percent, but the effect lasts only 3 to 4 hours. Matching that with cannabis would require six to eight doses per day, including doses during sleep. The American Academy of Ophthalmology, the National Eye Institute, and the American Glaucoma Society do not recommend cannabis for glaucoma.
Medical Cannabis for Glaucoma: Reviews, Risks, and Comparison
Dosage studies answer a narrow question: how much THC produces a short IOP drop. They do not show that cannabis prevents optic nerve damage or vision loss.
Benefits of Cannabis for Glaucoma Patients: A Comprehensive Guide
Why a Short IOP Drop Does Not Treat Glaucoma
Glaucoma damages the optic nerve over years. Treatment works by holding pressure down around the clock. Prescription prostaglandin drops lower IOP for 24 hours or more with one nightly dose. Cannabis produces a spike and crash pattern: pressure falls for a few hours, then returns to baseline. During the gap, the optic nerve is exposed again.
A person would need to wake through the night to dose. That schedule is not realistic, and the side effects of high THC doses make it harder to maintain.
medical marijuana for glaucoma symptoms relief
What Dosage Research Has Measured
Inhaled cannabis and THC
The most cited study gave participants a single marijuana cigarette containing about 900 mg of THC. IOP fell by 25 percent in most participants, and the effect lasted 3 to 4 hours. That THC content is far above what most people consume in one session. Lower doses produce a smaller and shorter drop.
Oral and sublingual THC
Oral THC doses of 5 to 20 mg lowered IOP in some studies, with a slower onset and a drop lasting 4 to 6 hours. Absorption varies from person to person, so the same dose can produce different pressure changes.
Topical cannabinoids
Eye drops made with THC or cannabidiol do not lower IOP well. The cornea blocks cannabinoids from reaching the ciliary body and trabecular meshwork, the tissues that control pressure. No topical cannabis product has approval for glaucoma.
Side Effects That Limit Frequent Dosing
- Impaired memory, attention, and coordination
- Drowsiness that interferes with driving and work
- Fast heart rate and blood pressure changes
- Dry mouth, dry eyes, and dizziness
- Anxiety or paranoia at high doses
- Dependence with daily use
Tolerance and Pressure Rebound
Repeated THC exposure builds tolerance in the CB1 receptors that mediate the IOP drop. Over days to weeks, the same dose produces less effect, and users may need more to get the same result. Some researchers also describe a rebound rise in pressure when the drug wears off, which is the opposite of what glaucoma care needs.
Prerequisites Before You Ask Your Eye Doctor
- A confirmed glaucoma diagnosis and current IOP readings
- A list of your current drops, doses, and side effects
- Any history of heart disease, anxiety, or substance use
- Records of any cannabis use, including product type and timing
Steps to Research This Safely With Your Care Team
- Ask your ophthalmologist for your latest IOP numbers and visual field results.
- Write down every prescription drop you use and when you use it.
- Record any cannabis use, including the product, amount, and time, in a log.
- Bring the log to your next appointment and ask whether it changes your pressure readings.
- Follow your prescribed drop schedule and do not replace it with cannabis.
- Report new eye pain, vision changes, or side effects right away.
The Bottom Line
Dosage research on cannabis and glaucoma is real, but it points away from cannabis as a treatment. The window of pressure control is short, the required dosing is constant, and no study shows that cannabis protects vision over time. Prescription drops, laser treatment, and surgery remain the standard of care.